Literature DB >> 858997

Hapten-specific delayed hypersensitivity to epsilon-2,4-dinitrophenyl-L-lysine-Ficoll in guinea pigs immunized with 2,4-dinitrophenyl-keyhole limpet hemocyanin.

P R McMaster, J D Owens, H F Dvorak, R Weichbrod, R Asofsky.   

Abstract

After active immunization with 2,4-dinitrophenyl-keyhole limpet hemocyanin (DNP-KLH), 2,4-dinitropheynl-L-lysine (DNPL)-Ficoll may elicit indurated, erythematous skin reactions lasting 24-72 h. Histological sections of these reactions, examined by microscope techniques, showed they contained polymorphonuclear leukocytes and perivascularly situated lymphocytes and macrophages, but had very few basophils. Consequently, the reaction was interpreted as having an immediate component and a component typical of delayed hypersensitivity; this indicated that the delayed reaction could be specific for the DNP hapten. Although this delayed type of skin reaction was not transferred to recipients with anti-DNP-KLH serum, one pool of that serum did sensitize guinea pigs so that they could respond with a different skin reaction after challenge with DNPL-Ficoll. This reaction was soft, pale pink, and lasted for 24 h. Histologically, it contained only a few polymorphonuclear leukocytes. It differed from the delayed reaction in actively immunized animals in that it lacked induration, and was devoid of lymphocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 858997      PMCID: PMC2180661          DOI: 10.1084/jem.145.5.1101

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Studies on hypersensitivity. I. Delayed and Arthustype skin reactivity to protein conjugates in guinea pigs.

Authors:  B BENACERRAF; P G GELL
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

2.  Studies on hypersensitivity. III. The relation between delayed reactivity to the picryl group of conjugates and contact sensitivity.

Authors:  B BENACERRAF; P G GELL
Journal:  Immunology       Date:  1959-07       Impact factor: 7.397

3.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

4.  Staining mast cells in sublimate-fixed guinea pig tissue.

Authors:  P T Donaldson; R D Lillie; P Pizzolato
Journal:  Stain Technol       Date:  1973-01

5.  Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer.

Authors:  H F Dvorak; B A Simpson; R C Bast; S Leskowitz
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

6.  Delayed hypersensitivity to hapten-protein conjugates. I. The effect of carrier protein and site of attachment to hapten.

Authors:  P G GELL; A M SILVERSTEIN
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

7.  A study of the distribution of 2,4-dinitrobenzene sensitizers between isolated lymph node cells and extracellular medium in relation to induction of contact skin sensitivity.

Authors:  H N EISEN; M KERN; W T NEWTON; E HELMREICH
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

8.  Immunochemical study of antigenic specificity in delayed hypersensitivity. II. Delayed hypersensitivity to polytyrosine-azobenzenearsonate and its suppression by haptens.

Authors:  S LESKOWITZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

9.  Delayed hypersensitivity to hapten-protein conjugates. II. Anti-hapten specificity and the heterogeneity of the delayed response.

Authors:  A M SILVERSTEIN; P G GELL
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

10.  Studies on hypersensitivity. IV. The relationship between contact and delayed sensitivity: a study of the specificity of cellular immune reactions.

Authors:  P G GELL; B BENACERRAF
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.